I’m pleased to share that VerumGen Labs will be participating in MSS 2026 (September 14–16 in Bled, Slovenia). I’ll be presenting two talks focused on our work Universal AAV Standard and AE1-BHK cell line:
• Universal AAV Standard: Advancing Standardization in AAV Genome Quantification and Quality Assessment
• AE1-BHK: A Novel E1-Complementing BHK Platform for Recombinant AAV Production
I’m also looking forward to a collaborative poster from VerumGen Labs, Niba Labs, and Agathos Biologics:
• Advancing AAV Analytics with a 4-Plex dPCR and Universal AAV Standard for Genome Integrity and Titer Assessment
Together, these presentations highlight several complementary aspects of our work, from improving AAV genome quantification and quality assessment to developing alternative platforms for AAV production.
Many thanks to the MSS 2026 organizers for the opportunity to present this work and for generously supporting my participation in the meeting. Looking forward to the discussions in Bled and to connecting with others working in AAV manufacturing, analytics, and gene therapy.